SAN DIEGO and VANCOUVER, British Columbia , Jan. 30, 2017 /CNW/ -- Sophiris Bio Inc. (SPHS) a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the BetterInvesting™ Virtual Investor Conference. The presentation will take place on Thursday February 2, 2017 at 1:00 p.m. Eastern Time
Market Data 
Markets 
AI
